Do Mushroom Gummies Work? What’s Actually in Them and What the Evidence Shows

Mushroom gummies can contain real mushroom ingredients, but whether they work depends on what kind you buy and how much is in each piece. Functional gummies usually hold far less mushroom than human trials used, sometimes as grain-grown mycelium, and no trial has tested a gummy. Psychoactive “mushroom” gummies are a separate and riskier category.

The phrase covers three products with almost nothing in common: functional mushroom sweets sold as supplements, edibles marketed as psilocybin “magic mushroom” products, and gummies made with Amanita muscaria. Each raises a different question. For functional gummies it is dose and identity; for the other two it is what the gummy really contains.

Below we compare label doses with trial doses, explain why fruiting body versus mycelium matters, summarise what laboratory testing of gummies has found, and list what to check before buying.

At a glance: the three kinds of mushroom gummies

Type	Claimed contents	US regulatory position	Main concern
Functional	Lion’s mane, reishi, cordyceps, chaga, turkey tail and similar	Sold as dietary supplements	Doses below trial levels; identity and mycelium content
Psilocybin-style	“Magic mushroom” blends, often unnamed	Psilocin is Schedule I federally1	Tested products often lacked psilocybin and held undisclosed drugs2,3
Amanita	Muscimol, ibotenic acid	FDA: not authorised in conventional food4	Poisoning risk; labels often inaccurate3

Psychoactive mushroom gummies: what testing and the FDA found

The Diamond Shruumz outbreak in 2024 is the clearest warning about unregulated psychoactive edibles. The FDA’s investigation, now closed, counted 180 illnesses in 34 states, 73 hospitalisations and three potentially associated deaths.¹ A 2026 CDC report on the same outbreak found 38 people needed intensive care and 29 needed a breathing tube.⁵ Reported symptoms included seizures, loss of consciousness, agitation and abnormal heart rates.¹

FDA testing of the chocolate bars, cones and gummies found an inconsistent mix: muscimol in some products, the synthetic tryptamine 4-AcO-DMT (psilacetin) and psilocin in 14 gummies, kavalactones, and the prescription drug pregabalin in four gummies. Results varied even within the same flavour.¹

Independent studies point the same way:

• Portland, eight gummies. Two products claiming Amanita extract contained no muscimol or ibotenic acid but did contain psilocin and other tryptamines. Seven of eight contained psilocin, six contained 4-AcO-DMT, one labelled psilocybin-free tested positive for psilocybin, and a “nootropic” product held undisclosed THC.³
• Oregon State University, 12 edibles. None of the gummies and chocolates sold as “magic mushroom” products contained psilocybin or muscimol. Researchers found undisclosed caffeine, kava and hemp extracts, and synthetic psychedelic compounds.^2,6
• Poison centre data. US poison centres logged 362 psychoactive mushroom edible exposures in 2023 and 2024; polysubstance exposure, confusion and central nervous system depression were linked to hospital admission.⁷

Put simply, a gummy sold as a “legal” or “microdose” mushroom product may contain something quite different from its label. Our comparison of Amanita muscaria and psilocybin mushrooms explains how the two chemistries differ.

Amanita gummies and the FDA

In December 2024 the FDA told manufacturers that Amanita muscaria and its constituents muscimol, ibotenic acid and muscarine are not authorised for use in conventional food. The agency concluded they do not meet the GRAS standard, are unapproved food additives, and advised people to avoid foods containing them.⁴ It was still evaluating their use in dietary supplements at the time.⁴

In September 2025 the FDA sent a warning letter to a New York company selling Amanita capsules, a tincture and a chocolate bar. It treated the ingredients in the supplements as new dietary ingredients without adequate safety evidence, deemed the chocolate a conventional food containing an unapproved additive, and cited concerns including delirium, seizures, coma, respiratory depression and death.⁸ State rules differ; our 2026 Amanita muscaria explainer tracks them.

Functional mushroom gummies: label doses versus trial doses

The more common question is whether a lion’s mane or reishi gummy can match the research. The answer is usually no on dose alone. In label records held by the NIH Dietary Supplement Label Database, single-ingredient lion’s mane gummies list 500 mg to 1 g per serving of one to three gummies. The same ten-mushroom formula, listing 250 mg of each species per two-gummy serving, appears under several brand names, and one “microdosed” gummy lists 16.67 mg each of lion’s mane, reishi and cordyceps.⁹

Mushroom	Dose used in human trials	What the trials found
Lion’s mane	About 3 g/day dried mushroom powder for 16 weeks; 1.8 g/day for 28 days	Better cognitive scores in 30 older adults with mild impairment, fading after stopping10; mixed results in 41 young adults11
Reishi	1.4 to 3 g/day for 12 to 16 weeks	No significant effect on HbA1c, fasting glucose or cholesterol in people with type 2 diabetes, per a Cochrane review12
Cordyceps	1 g/day Cs-4 for 12 weeks; 4 g/day blend for 3 weeks	Small exercise-threshold gains in 20 older adults13; no change at one week in 28 young adults, some gains at three weeks in a 10-person subgroup14
Chaga	No controlled human trials found	Kidney injury case reports at high intakes15,16

So a 250 mg share of a blend is roughly a twelfth of the lion’s mane dose in the best-known trial.^10,9 Getting to 3 g would take several servings, and with them several grams of sugar. Extracts complicate the arithmetic, because a concentrated extract may represent more raw mushroom. Without a stated extract ratio and a measured marker such as beta-glucan, the label cannot tell you. Our overview of nine functional mushrooms and their research covers the wider evidence, and reishi vs lion’s mane compares the two most common gummy ingredients.

Chaga deserves a specific caution. Two case reports describe oxalate kidney damage, one in a woman taking four to five teaspoons of chaga powder a day for six months and one in a man taking 10 to 15 g a day for three months.^15,16 Gummy doses are far lower, but anyone with kidney disease should take advice first. See chaga vs reishi for more.

Fruiting body vs mycelium on grain, and beta-glucan testing

Mushroom ingredients come from two sources. The fruiting body is the mushroom itself. Mycelium is the root-like network, often grown on rice, oats or other grain and dried with that grain still in it. Labels sometimes describe this as “myceliated grain” or “fermented brown rice biomass”, which is how one lion’s mane gummy in the label database describes its mushroom ingredient.⁹

The distinction matters because grain is mostly starch. A peer-reviewed method from Megazyme measures total glucan, then subtracts alpha-glucan (starch and glycogen) to give beta-glucan, the polysaccharide fraction usually cited for mushrooms.¹⁷ Simpler “total polysaccharide” tests can count starch as if it were beta-glucan.¹⁸

Using that approach, a white paper from Nammex, a fruiting-body supplier with an obvious commercial interest, reported fruiting bodies at roughly 30 to 40% beta-glucan and grain-grown mycelium averaging about 5 to 7%, with starch around 35 to 40%.¹⁸ Independent label studies show quality problems too:

• Only 5 of 19 batches of reishi supplements bought in the US matched their labels for key triterpenes and polysaccharides.¹⁹
• DNA testing found 93% of manufactured reishi products were Ganoderma lingzhi, not the G. lucidum on the label; none contained true G. lucidum, and some held other species.²⁰

Our report on the 2026 functional mushroom market and its label problems goes further into these issues.

Sugar content in mushroom gummies

Gummies are sweets. Two lion’s mane gummy labels in the NIH database list 4 g of total sugars per serving of two or three gummies.⁹ That is modest on its own, but the FDA’s Daily Value for added sugars is 50 g on a 2,000-calorie diet,²¹ and taking several servings to approach trial doses, or stacking several gummy supplements, adds up. People managing diabetes or watching sugar intake should count gummies as food.

So, do mushroom gummies work?

For psychoactive gummies, the honest answer is that you often cannot know what you are taking, which makes “working” beside the point. For functional gummies, there is no trial of any gummy product, and the small trials of the underlying mushrooms used doses several times higher than most gummy servings. Lion’s mane has the most promising early data, but it comes from small studies and the benefit in the best-known trial faded within four weeks of stopping.¹⁰ Side effects reported in trials are covered in our guide to lion’s mane side effects.

A gummy can still be a convenient way to take a small amount of a food-grade mushroom. It is not a reliable way to reproduce the research.

What to check before buying mushroom gummies

1. Species and Latin name, such as Hericium erinaceus for lion’s mane.
2. Part used: fruiting body, mycelium, or mycelium with grain. “Biomass” and “myceliated” usually mean grain is included.
3. Milligrams per species per serving, not just a blend total, and the extract ratio if it is an extract.
4. Beta-glucan and starch results on a batch certificate of analysis, ideally by a Megazyme-type method, plus heavy metal and microbial results. Our guide to signs a brand is genuinely third-party tested explains what to look for.
5. Sugar per serving, multiplied by how many servings you would actually take.
6. Red-flag wording: “legal high”, “microdose”, “magic” or Amanita. These are not functional supplements.
7. Medicines. Ask a pharmacist if you take blood thinners, diabetes drugs or immunosuppressants.

If you prefer capsules or powders, our best lion’s mane brands of 2026 guide compares labels on the same criteria.

Frequently asked questions

Do mushroom gummies actually work?

There is no clinical trial of any mushroom gummy. Trials of the mushrooms themselves used larger amounts, for example about 3 g a day of lion’s mane powder for 16 weeks,¹⁰ while many gummy servings contain 250 mg to 1 g.⁹ Gummies may provide a small amount of mushroom, but they are unlikely to reproduce trial doses without several servings.

Are mushroom gummies psychedelic?

Functional gummies made from lion’s mane, reishi or cordyceps are not psychedelic. Gummies sold as magic mushroom or Amanita products are a different category, and testing has found many contain undisclosed substances such as synthetic tryptamines, kava or THC instead of what the label claims.^3,2 The FDA linked one such brand to 180 illnesses in 2024.¹

Are lion’s mane gummies as good as capsules?

Not necessarily worse, but usually lower dose. Lion’s mane gummy labels in the NIH database list 500 mg to 1 g per serving,⁹ and gummies add sugar. Capsules or powders make it easier to reach the gram-level amounts used in trials. In either format, check whether the ingredient is fruiting body or mycelium grown on grain, and look for a beta-glucan result.

Are Amanita mushroom gummies legal?

In December 2024 the FDA said Amanita muscaria and its constituents, including muscimol, are not authorised in conventional food and advised people to avoid foods containing them.⁴ It has since issued warning letters over Amanita supplements and edibles.⁸ State laws vary, so check local rules. Testing has also found gummies sold as Amanita that contained no muscimol at all.³

What should I look for on a mushroom gummy label?

Look for the Latin species name, whether the ingredient is fruiting body or mycelium, milligrams per species per serving, and the extract ratio. A batch certificate of analysis should report beta-glucan and starch, ideally using a Megazyme-type method, plus heavy metals.¹⁷ Avoid products promoting a high, microdosing or Amanita content.

Sources

1. US Food and Drug Administration. Investigation of Illnesses: Diamond Shruumz-Brand Chocolate Bars, Cones, & Gummies (June 2024). Content current as of 15 November 2024. fda.gov
2. van Breemen RB, Simchuk D, Fritzsche B, Huson D, Kuzdzal SA, Ferguson J. Active Constituents of Psilocybin Mushroom Edibles. JAMA Netw Open. 2025;8(9):e2531345. DOI: 10.1001/jamanetworkopen.2025.31345. PMID: 40932719. pubmed.ncbi.nlm.nih.gov
3. Correia MS, Gonzaga MJ, Temple C, Gerona RR. Quantitative analysis of recreational psychoactive mushroom gummies in Portland, Oregon. Clin Toxicol (Phila). 2025;63(4):261-266. DOI: 10.1080/15563650.2025.2450240. PMID: 39977248. pubmed.ncbi.nlm.nih.gov
4. US Food and Drug Administration. FDA Alerts Industry and Consumers About the Use of Amanita Muscaria or Its Constituents in Food. 18 December 2024. fda.gov
5. Rumph JT, Winquist A, Troeschel AN, Pulver S, Schnall AH, Ebersole J, et al. Severe Illness Associated with Eating Mushroom-Containing Chocolate Products – United States, January-October 2024. MMWR Morb Mortal Wkly Rep. 2026;75(13):179-184. DOI: 10.15585/mmwr.mm7513a2. PMID: 41955162. pubmed.ncbi.nlm.nih.gov
6. Oregon State University. Analysis of ‘magic mushroom’ edibles finds no psilocybin but many undisclosed active ingredients. News release, 11 September 2025. news.oregonstate.edu
7. Jorgenson DM, Santos Leon E, Vakkalanka JP, Krispin S, Radke JB. Psychoactive mushroom edibles: trends and toxicities reported to the United States National Poison Data System, 2023-2024. Clin Toxicol (Phila). 2026;64(3):192-199. DOI: 10.1080/15563650.2025.2599402. PMID: 41493095. pubmed.ncbi.nlm.nih.gov
8. Food Safety News. FDA warns Blue Forest Farms over adulterated Amanita muscaria products. 22 September 2025. foodsafetynews.com
9. National Institutes of Health, Office of Dietary Supplements. Dietary Supplement Label Database: gummy label records 335814, 318045, 313329, 277131 and 322795. Accessed 24 October 2026. dsld.od.nih.gov
10. Mori K, Inatomi S, Ouchi K, Azumi Y, Tuchida T. Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double-blind placebo-controlled clinical trial. Phytother Res. 2009;23(3):367-372. DOI: 10.1002/ptr.2634. PMID: 18844328. pubmed.ncbi.nlm.nih.gov
11. Docherty S, Doughty FL, Smith EF. The Acute and Chronic Effects of Lion’s Mane Mushroom Supplementation on Cognitive Function, Stress and Mood in Young Adults: A Double-Blind, Parallel Groups, Pilot Study. Nutrients. 2023;15(22):4842. DOI: 10.3390/nu15224842. PMID: 38004235. pubmed.ncbi.nlm.nih.gov
12. Klupp NL, Chang D, Hawke F, Kiat H, Cao H, Grant SJ, Bensoussan A. Ganoderma lucidum mushroom for the treatment of cardiovascular risk factors. Cochrane Database Syst Rev. 2015;(2):CD007259. DOI: 10.1002/14651858.CD007259.pub2. PMID: 25686270. pubmed.ncbi.nlm.nih.gov
13. Chen S, Li Z, Krochmal R, Abrazado M, Kim W, Cooper CB. Effect of Cs-4 (Cordyceps sinensis) on exercise performance in healthy older subjects: a double-blind, placebo-controlled trial. J Altern Complement Med. 2010;16(5):585-590. DOI: 10.1089/acm.2009.0226. PMID: 20804368. pubmed.ncbi.nlm.nih.gov
14. Hirsch KR, Smith-Ryan AE, Roelofs EJ, Trexler ET, Mock MG. Cordyceps militaris Improves Tolerance to High-Intensity Exercise After Acute and Chronic Supplementation. J Diet Suppl. 2017;14(1):42-53. DOI: 10.1080/19390211.2016.1203386. PMID: 27408987. pubmed.ncbi.nlm.nih.gov
15. Kikuchi Y, Seta K, Ogawa Y, Takayama T, Nagata M, Taguchi T, Yahata K. Chaga mushroom-induced oxalate nephropathy. Clin Nephrol. 2014;81(6):440-444. DOI: 10.5414/CN107655. PMID: 23149251. pubmed.ncbi.nlm.nih.gov
16. Kwon O, Kim Y, Paek JH, Park WY, Han S, Sin H, Jin K. Chaga mushroom-induced oxalate nephropathy that clinically manifested as nephrotic syndrome: A case report. Medicine (Baltimore). 2022;101(10):e28997. DOI: 10.1097/MD.0000000000028997. PMID: 35451393. pubmed.ncbi.nlm.nih.gov
17. McCleary BV, Draga A. Measurement of beta-Glucan in Mushrooms and Mycelial Products. J AOAC Int. 2016;99(2):364-373. DOI: 10.5740/jaoacint.15-0289. PMID: 26957216. pubmed.ncbi.nlm.nih.gov
18. Chilton J (Nammex). Redefining Medicinal Mushrooms: A new scientific screening program for active compounds. Industry white paper hosted by Megazyme, undated. megazyme.com
19. Wu DT, Deng Y, Chen LX, Zhao J, Bzhelyansky A, Li SP. Evaluation on quality consistency of Ganoderma lucidum dietary supplements collected in the United States. Sci Rep. 2017;7(1):7792. DOI: 10.1038/s41598-017-06336-3. PMID: 28798349. pubmed.ncbi.nlm.nih.gov
20. Loyd AL, Richter BS, Jusino MA, Truong C, Smith ME, Blanchette RA, Smith JA. Identifying the “Mushroom of Immortality”: Assessing the Ganoderma Species Composition in Commercial Reishi Products. Front Microbiol. 2018;9:1557. DOI: 10.3389/fmicb.2018.01557. PMID: 30061872. pubmed.ncbi.nlm.nih.gov
21. US Food and Drug Administration. Added Sugars on the Nutrition Facts Label. Updated 4 March 2026. fda.gov

This article is for educational purposes only and is not medical or legal advice. Products discussed here are not intended to diagnose, treat, cure or prevent any disease. Laws vary by location and change often, so verify the rules that apply where you are. Always talk to a licensed healthcare provider before use, especially if you are under 21, pregnant or nursing, taking medication, or managing a health condition.